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Streptococcus suis is an important swine and human pathogen, and it has presented a considerable 
challenge to the global public health community. Domínguez-Punaro et al. (2007) showed that two 
strains of mice were differentially susceptible to S. suis. The attainment of information on the 
differential expression of host response genes following S. suis infection is relevant to the 
understanding of the molecular mechanism of this disease. The intent of this study was to select and 
isolate differentially expressed genes from A/J and C57BL/6 mice that are associated with the host 
response to S. suis infection. These baseline data will allow for the screening and cloning of specific 
resistance genes, and further our understanding of the molecular mechanism of S. suis infection. Eight-
week-old C57BL/6 and A/J mouse were infected with S. suis serotype 2, a 200-µL volume of a bacterial 
suspension (1 × 10
8
 CFU/mL) was administrated by intraperitoneal injection to the mice, and cDNA 
subtraction libraries were constructed by suppression subtraction hybridization (SSH). Genes involved 
in immune function, such as lysozyme, interferon-active protein, macrophage activation 2-like protein, 
complement component-3 and Ly108 protein were up-regulated in the spleen of C57BL/6 mice to a 
greater extent than they were in the spleen of A/J mice, subsequent to infection with S. suis serotype 2. 
Interestingly, we observed that several splenic signaling factors associated with phospholipid 
metabolism were up-regulated to a greater extent as well in C57BL/6 mice than they were in A/J mice 
following infection with S. suis serotype 2. These data suggest that phospholipid metabolism may be 
involved in the host defense response to S. suis invasion, thereby contributing to the organism’s 
overall immune response to this pathogen. 
 
Key words: Streptococcus suis serotype 2, suppression, subtractive hybridization, differentially expressed 





Streptococcus suis (S. suis) is an important zoonotic 
pathogen and is implicated in the etiology of several 
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pneumonia and septicemia (Gottschalk and Segura., 
2000; Messier et al., 2008). The ability of S. suis to cause 
disease is not limited to swine. A severe outbreak of 
invasive infection in humans and pigs occurred in 
Sichuan and Jiangsu Provinces, resulting in high levels of 
mortality (Tang et al., 2006; Feng et al., 2009). S. suis 
infection has also caused sporadic human illness in 





al., 2008; Navacharoen et al., 2009), the United Kingdom 
(Watkins et al., 2001), Portugal (Taipa et al., 2008), the 
Netherlands (van de Beek et al., 2008), the United States 
(Smith et al., 2008; Fittipaldi et al.,2009), and in Australia 
(Tramontana et al., 2008), and it has been recognized as 
the most common cause of adult meningitis in Vietnam 
(Wertheim et al., 2009). Although 35 serotypes have been 
described to date, S. suis serotype 2 (SS2) is still the 
most virulent and frequently isolated form of the disease 
in animals (Higgins and  Gottschalk.2005). Due to the 
serious public health risk imposed by SS2, focused 
research efforts on S. suis are warranted. Previous 
studies have been performed primarily on the pathogenic 
bacteria and on a several virulence-associated factors, 
including Rgg (Zheng et al., 2011), LuxS (Wang et al., 
2011; Cao et al., 2011), enolase (Esgleas et al., 2008; 
Feng et al., 2009; Zhang et al., 2009), fibronectin-binding 
protein (de Greeff et al., 2002), glyceraldehyde-3-
phosphate dehydrogenase (Brassard et al., 2004), and 
IgA1 protease (Zhang et al., 2010). However, the 
pathogenesis of S. suis infection is not fully understood. 
In studies, it has been suggested that the host response 
plays an essential roles in the development of the 
disease (Li et al., 2010). Domínguez-Punaro Mde et al. 
(2008) showed that A/J mice were more susceptible than 
C57BL/6 mice to S. suis infection. They also confirmed 
that IL-10 was responsible, at least in part, for the high 
survival rate, which suggests that an aberrant innate 
immune response contributes to the development of SS2 
diseases (Domínguez-Punaro Mde et al., 2008). 
Therefore, in order to better understand the molecular 
mechanism of the disease process, it is necessary to 
screen and identify differentially expressed genes 
associated with the host response to S. suis infection. In 
this study, a subtractive hybridization library was 
constructed, and differentially expressed genes from the 
spleen of C57BL/6 and A/J mice infected with S. suis 
serotype 2 were analyzed. Differentially expressed gene 
functional analyses can provide baseline data that will be 
useful for the screening and cloning of specific resistant 
genes, and they may also contribute to a better 








The TRIZOL reagent kit was purchased from Invitrogen (CA, USA), 
the Oligotex® mRNA Kits from Qiagen (Germany), the PCR-
Select
TM
 cDNA subtraction kit, Advantage cDNA PCR kit and 
Polymerase Mix from Clontech (USA), and the 2 × Taq PCR Master 
Mix, Agarose Gel DNA purification kit, pMD
®
19-T Vector, DNA 
marker DL-2000, Ф×l74-Hae III digest from TaKaRa Bio Inc. (Shiga, 
Japan). The E.Z.N.A. cycle-pure kit (Omega, USA), Regular 
agarose G-10, tryptone and yeast extract were obtained from 
Tiangen Biotechnology Institution (Nanjing, China), and the Tris-
phenol was purchased from Beijing Shuangxiang Biotechnology 
Institution (Beijing, China). 




Bacterial strain and culture conditions 
 
The HA9801 strain of SS2 was isolated in 1998 from diseased pigs 
in Jiangsu province, and it was confirmed virulent through animal 
experimentation (Zhang and Lu.,2007; Wu et al., 2008). Bacteria 
were grown overnight in Todd-Hewitt broth (THB) at 37°C, and 
isolated colonies were then inoculated in 2-mL of THB and 
incubated for 8 h at 37°C while being agitated. Working cultures 
were prepared by transferring 100 µL of 1:100 dilutions of the 8 h 
culture media into 10-mL of THB, which was further incubated and 
agitated for 12 h at 37°C. Stationary-phase bacteria were washed 
twice in phosphate-buffered saline (PBS) (pH 7.4). The bacterial 
pellet was re-suspended and adjusted to a concentration of 3.89 × 
10
8
 CFU/mL, and this solution was diluted in THB to a final 
concentration of 1 × 10
8
 CFU/mL (Domínguez-Punaro Mde et al., 




Animal and sample preparation 
 
Eight-week-old C57BL/6 and A/J mice (obtained from the 
experiment center, Nanjing University, Jiangsu Province, China) 
were acclimatized to a standard 12-h-light/12-h-dark cycle, and they 
were allowed free access to rodent chow and water. All animal 
handling procedures were performed in strict accordance with 
guidelines established by the People’s Republic of China. On the 
day of the experiment, 200 µL of the bacterial suspension (1 × 10
8
 
CFU/mL) were administrated to the animals by intraperitoneal 
injection. All mice were sacrificed at 72 h post-injection. Tissue 
samples obtained from the spleen were immediately frozen in liquid 
nitrogen and stored at -80°C for subsequent analysis. 
 
 
RNA extraction, cDNA synthesis and SSH 
 
Total RNA was isolated from spleen tissue using the TRIZOL 
reagent kit, according to the manufacturer’s instructions. The RNA 
concentration was quantified by measuring absorbance at 260 nm 
in a photometer (Eppendorf Biophotometer). Absorption ratios 
(260/280 nm) for all preparations were between 1.8 and 2.0. RNA 
sample aliquots were subjected to electrophoresis through a 1.0% 
agarose/formaldehyde gel to verify their integrity. The mRNA was 
extracted to determine total RNA, using the Oligotex mRNA kit, 
according to the manufacturer’s instructions, and in each case, 
spleen samples from multiple individuals were pooled to extract 
mRNA for subtraction. 
Subtractive hybridization libraries, including SSH-TA (a forward 
library tester cDNA using A/J mouse spleen, and a driver cDNA 
using C57BL/6 mouse spleen) and SSH-TB (a reverse library tester 
cDNA using C57BL/6 mouse spleen, and a driver cDNA, using A/J 
mouse spleen) were constructed using a PCR-Select
TM
 cDNA 
subtraction kit according to the manufacturer’s instructions, as 
schematically described in Figure 1. Briefly, cDNA was generated 
from 2 µg of poly (A+) mRNA from each of the tester and driver 
populations, and it was converted by reverse transcription and 
digestion with Rsa I (1.5 h at 37°C) to produce short, blunt-ended 
fragments. The tester cDNA was subdivided into two portions and 
ligated with a different adaptor that was provided in the cDNA 
subtraction kit (Clontech). Ligation efficiency was evaluated by 
PCR, using primers specific to human skeletal muscle G3PDH gene 
sequences, and then two hybridization steps were performed. For 
the first hybridization, an excess of the driver cDNA was added to 
each of the adaptor-ligated tester samples and then heat-denatured 
and allowed to anneal. In the second hybridization, the two primary 
hybridization samples were mixed together without denaturizing 
them, and nested PCR amplification was then performed. After 
amplifying the tester-specific sequences of hybridization samples by  




Tester and driver cDNA are separately digested
to obtain shorter, blunt-ended molecules
Rsa I digestion
Tester and driver ds cDNA are prepared from the 
two mRNA sample under comparison
cDNA synthesis
Differentially exp ressed sequences are
equalized and enriched
First hybridization
Two tester populations are created with different 
adaptors. Driver cDNA has no adaptors
Adaptor ligation
Templates for PCR amplification are generated
from d ifferentially expressed sequences
Second hybridization
Only differentially exp ressed sequences are
exponentially amplified by Suppression PCR
First PCR Amplification                       
Only differentially exp ressed sequences are
exponentially amplified by Suppression PCR
Second PCR Amplification                       
 
 




PCR, the specific fragments obtained were ligated to pMD
®
19-T 
vectors. The ligation mixture was then transformed into Escherichia 
coli DH-5α cells and cultured on Luria Bertani (LB) agarose plates 
containing ampicillin and X-Gal/IPTG. The white clones were 
selected to construct the forward and reverse subtracted cDNA 
library. A total of 421 recombinant clones were selected randomly 
and verified by PCR to check the quality of the library. 
 
 
Detection of positive clones 
 
All white clones were selected from LB plates and added to 200 µL 
of liquid LB medium containing 100 µg/mL of ampicillin and  shaken 
for 6 h at 37°C. The cDNA inserted fragments were amplified using 
the nested PCR primers 1 (5’-TGCAGCGGCCGCCCGGGCAGGT-
3’) and 2R (5’-AGCGTGGTCGCGGCCGAGGT-3’) that were 
provided in the PCR-selected cDNA subtraction kit, and insert 
fragments were detected by 2.0% agarose gel electrophoresis. 
 
 
Sequencing, expressed sequence tags (ESTs) and 
bioinformatics analysis 
 
All selected clones were sequenced by Shanghai Majorbio Bio- 
Pharm Technology Co. (Shanghai, China). After removing low 
quality bases,  uninformative  sequences,  adaptor  sequences  and 




Table 1. Mortality of HA9801 strain on A/J mice and C57BL/6 mice. 
 
Strain Infection dose Mice strain Amount of mice Death/Total Mortality (%) 
HA9801 10
8
 A/J 16 11/16 68.75 
HA9801 10
8




 SSH-TA library (forward library) 
Subtracted           Unsubtracted
SSH-TB library (reverse library) 





M   18    23    28   33   18    23    28   33       M   18   23 28   33   18   23   28   33
 
 
Figure 2. Reduction in G3PDH gene abundance by suppression subtractive hybridization. PCR analysis was performed on 
subtracted and unsubtracted secondary PCR products for different cycles in forward library (SSH-TA) and reverse library 





vector sequences, each unidentified sequence was subjected to 
BlastX and BlastN alignment against the non-redundant (nr) protein 
database and GenBank database 
(http://www.ncbi.nlm.nih.gov/BLAST/). Database searches were 
limited to ESTs > 100 bp in length, and matches with a bit score 
higher than 40 were considered significant. To further study the 
function and characteristics of differentially expressed genes, 
sequence analysis using online GO (Gene ontology category, 
http://www.geneontology.org/) software was employed to obtain 







The mortality rates for the A/J and C57BL/6 mice 
following injection with the HA9801 suspension are 
shown in Table 1. Mortality for the A/J and C57BL/6 mice 
were 68.75 and 25.0%, respectively. This indicates that 
the A/J mice were more susceptible to HA9801 than were 





Subtraction efficiency was evaluated by PCR 
amplification of the G3PDH housekeeping gene. If 
subtraction is efficient, a reduction in the housekeeping 
gene transcripts should be observed. A comparison of 
abundance before and after subtraction suggests that the 
quantity of G3PDH gene was significantly reduced 
following subtraction (Figure 2). The PCR products of the 
G3PDH gene can be observed after 23 and 33 cycles for 
unsubtracted and subtracted cDNAs, which indicates that 
G3PDH abundance was theoretically reduced by ~2(33-
23) = 210. The results indicate that specific genes in the 
spleen of A/J and C57BL/6 mice infected with SS2 strain 
HA9801 were enriched by ~210 times by SSH. 
 
 
PCR product examination of differentially expressed 
cDNAs 
 
All differentially expressed cDNA clones (total 441) were 
screened by PCR amplification from the two subtraction 
libraries. As some of the clones were found several times, 
174 clones from the SSH-TA library and 183 clones from 
the SSH-TB library were successfully amplified. The 
maximum efficiency was 84.8% in the two subtraction 
libraries. Agarose gel electrophoresis results show that 
the cDNA insert size ranged from 150 to 720 bp following 
removal of the primer and adapter sequences (Figure 3). 
 
 
EST sequence analysis 
 
Production of ESTs from SSH library 
 
Three hundred and fifty-seven ESTs were obtained from 
the SSH library after low-quality and repeated sequences 
were   eliminated . BLAST was used to analyze ESTs with 
database nucleotide collection (nr/nt), as some ESTs 
shared overlapping   regions,   or    represented   different  

























fragments of the same gene. Finally, the results revealed 
that 116 EST fragments from the SSH-TA library and 138 
EST fragments from the SSH-TB library were highly 
homologous (> 95%), with known sequences deposited in 
GenBank. All EST sequences listed in Table 2 (from the 
SSH-TA library) and in Table 3 (from the SSH-TB library) 
were deposited in GenBank. Also, three EST fragments 
from the SSH-TA library and two EST fragments from the 
SSH-TB library were novel genes with no homology 
within the GenBank database (data not shown). 
 
Basic function annotation 
 
To assess the role of the ESTs, gene-ontology was used 
for functional annotation of the differentially expressed 
genes. The results indicate that binding sequences (25%) 
contribute to the majority of the total unique transcripts 
obtained in the SSH-TA library, followed by genes 
involved in physiological pathways (15%), transcription 
and translation (14%), signal transduction (11%), 
regulatory enzyme activity (10%), catalytic activity (6%), 
cytes pathways (5%), development (4%), transport (4%) 
and unknown functions (6%) (Figure 4A). The results 
indicate that genes involved in binding sequences (21%) 
are also the largest contributor to the total obtained in the 
SSH-TB library, followed by physiological pathways 
(19%), transcription and translation (14%), signal 
transduction (12%), catalytic activity (7%), regulatory 
enzyme activity (6%), regulatory apoptosis (5%), cytes 
pathways (4%), transport (4%), development (3%) and 
unknown functions (5%) (Figure 4B). Interestingly, the 
regulatory signal transduction genes increased from 11% 
in the SSH-TA library to 12% in the SSH-TB library, and 
regulatory   cell  apoptosis  genes  appeared  only  in  the 
SSH-TB library. The data indicate that C57BL/6 mice 
cells may be more susceptible to apoptosis following 
infection with the S. suis pathogen than are cells from A/J 
mice. 
 
Putative differentially expressed proteins 
 
To determine the primary cell functions of the 254 unique 
transcripts identified through significant matches, we 
subjected them all to Blast homology searches, and a 
summary of these searches is contained in Table 4. 
Some proteins that were expressed in C57BL/6 mice 
have been implicated in general and specific disease 
resistance mechanisms, and in the body’s immune 
response. Others are involved in cell signal transduction 
and as membrane proteins, transcriptional factors and 
biological activity regulators. However, relatively few 
binding proteins were differentially expressed in A/J mice. 
As well, some proteins were differentially expressed both 
in A/J and C57BL/6 mice (data not shown). Interestingly, 
as many as eight differentially expressed proteins, as 
identified by BLAST software analysis, may have 
impacted upon anti-disease activity in C57BL/6 mice, 
including interferon activity protein, lysozyme, Ly108 
protein, macrophage activation 2 like protein, 
complement component-3, phosphatase, 
phosphatidylserine decarboxylase, serine/threonine 





A severe S. suis outbreak in humans and pigs has 
seriously   challenged   public   health   officials    in




Table 2. List of identified genes from SSH-TA library. 
 
Classification Identified gene 
GenBank accession 





M. musculus DNA for desmin-binding fragment DesA7 AJ403263.1 409 96 3E-168 
M. musculus DNA for desmin-binding fragment DesA17 AJ403273.1 512 91 2E-145 
M. musculus DNA for desmin-binding fragment DesA25 AJ403281.1 392 94 2E-86 
M. musculus DNA for desmin-binding fragment DesB4 AJ403301.1 402 95 3E-89 
M.musculus DNA for desmin-binding fragment DesB15 AJ403312.1 508 91 9E-134 
M.musculus DNA for desmin-binding fragment DesB16 AJ403313.1 569 90 3E-153 
M. musculus DNA for desmin-binding fragment DesB20 AJ403317.1 519 91 3E-143 
M. musculus DNA for desmin-binding fragment DesB29 AJ403326.1 545 93 4E-157 
M. musculus DNA for desmin-binding fragment DesB38 AJ403335.1 431 92 1E-157 
M. musculus DNA for vimentin-binding fragment VimC35 AJ403170.1 460 94 2E-109 
M. musculus DNA for vimentin-binding fragment VimC44 AJ403179.1 498 92 1E-137 
M. musculus DNA for vimentin-binding fragment VimE5 AJ403237.1 627 89 5E-176 
M. musculus DNA for vimentin-binding fragment VimE9 AJ403241.1 455 97 3E-168 
M. musculus DNA for vimentin-binding fragment VimE22 AJ403254.1 488 93 3E-83 
M. musculus DNA for GFAP-binding fragment GFAPE3 AJ403645.1 309 95 8E-164 
M. musculus DNA for GFAP-binding fragment GFAPE11 AJ403653.1 354 93 2E-81 
Mus musculus guanylate binding protein 4 (Gbp4), mRNA NM_008620.3 221 99 9E-109 
Mus musculus guanylate binding protein 6 (Gbp6), mRNA NM_194336.2 232 93 5E-91 
poly(A) binding protein, cytoplasmic 1 (Pabpc1 protein) AAH04587.1 503 100 7E-16 
poly(A) binding protein, cytoplasmic 2 AAB70164.1 338 75 5E-08 
poly(A) binding protein, cytoplasmic 4 CAM46095.1 398 100 1E-11 
poly(A) binding protein, cytoplasmic 6 EDL02091.1 362 80 3E-10 
Mus musculus RNA binding motif protein 39 (Rbm39), mRNA NM_133242.2 498 99 0 
Murine gene 37 for pot. membrane bound protein Y00629.1 307 96 7E-55 
Rattus norvegicus RNA-binding region containing protein 2-like, mRNA NM_001177904.1 528 95 5E-146 
Mus musculus poly(A)binding protein, cytoplasmic-1, mRNA, complete cds BC003870.1 343 99 5E-146 
M. musculus mRNA for poly(A) binding protein X65553.1 347 100 3E-128 
      
Physiology 
pathway 
Mus musculus mRNA for mKIAA4245 protein AK220567.1 303 99 1E-111 
Mus musculus mRNA for estrogen responsive finger protein, complete cds D63902.1 365 99 1E-142 
Mus musculus premature mRNA for mFLJ00102 protein AK220304.1 408 98 8E-174 
Mus musculus glucocorticoid-attenuated response gene 49(GARG-49/IRG2) mRNA, complete cds U43086.1|MMU43086 604 99 7E-135 
HUMRNPB1A Human hnRNP B1 protein mRNA M29064.1 465 99 0 
Homo sapiens mRNA for BM-010 variant protein AB209021.1 190 95 3E-79 
Mus musculus tripartite motif-containing 25 (Trim25), mRNA NM_009546.2 372 98 8E-159 




Table 2 Contd 
 
 
Samd9l protein (sterile alpha motif domain containing 9-like) AAH31151.2 781 100 4E-84 
Pb-fam-2 protein XP_675977.1 407 77 E-133 
      
Catalytic 
activity 
Mus musculus GTF2IRD1 and CYLN2 genes complete cds AF289667.1|AF289667 273 94 9E-79 
AF081957 Synthetic construct aminoglycoside 3'-phosphotrans ferase mutant (mNeo) gene AF081957.1 258 100 2E-11 
Mus musculus GTPase, IMAP family member 6 (Gimap6), mRNA BC028779.1 408 98 2E-170 
Rattus norvegicus NCK associated protein 1 like (Nckap1l), mRNA NM_001108119.1 459 92 1E-151 
PREDICTED: Mus musculus heterogeneous nuclear ribonucleoproteins A2/B1-like (LOC100045191) XM_001473825.2 470 100 4E-47 




Mus musculus eukaryotic translation initiation factor 4A2 (Eif4a2), mRNA BC094422.1 223 98 1E-107 
Mus musculus eukaryotic translation initiation factor 4A2 (Eif4a2), transcript variant 3, mRNA NM_001123038.1 199 100 9E-99 
Homo sapiens replication factor C (activator 1) 4 (37kD) (RFC4) gene, complete cds AF538718.1 201 95 3E-79 
Mus musculus eukaryotic translation elongation factor 1 alpha 1, mRNA, complete cds BC108391.1 308 100 2E-135 
MUSMHCQA1A Mus musculus MHC class I Qa-1a antigen mRNA, complete cds L00606.1 319 99 4E-132 
Rattus norvegicus similar to chromosome 1 open reading frame 63, mRNA, complete cds BC085888.1 359 87 2E-124 
MUSSATA Mouse satellite DNA M17407.1 389 94 1E-152 
Human DNA sequence from clone RP11-449I17 on chromosome 10, A transcriptional regulator(yeast) (SIN3A) and a 
CpG island, complete sequence 
AL161651.13 580 80 5E-116 
Mus musculus PRP38 pre-mRNA processing factor 38 (yeast) domain containing B, mRNA NM_025845.2 388 100 7E-80 
PRP38 pre-mRNA processing factor 38 (yeast) domain containing B BAB30042.1 298 100 1E-25 
      
Signal 
transduction 
Mus musculus KH domain containing, RNA binding, signal transduction associated 1, mRNA NM_011317.3 433 99 2E-180 
Homo sapiens mRNA for proto-oncogene protein, complete cds D14497.1|HUMPOPSTK 528 79 3E-108 
Mus sp. JAK1 protein tyrosine kinase mRNA, complete cds S63728.1|S63728 284 99 2E-110 
Homo sapiens mitogen-activated protein kinase kinase kinase 8 (MAP3K8), mRNA NM_005204.2 563 80 5E-116 
Clk4 protein AAH02220.1 355 83 6E-62 
Homo sapiens cDNA FLJ56064 complete cds, highly similar to Dual specificity protein kinase CLK1 AK294295.1 426 86 2E-145 
Human protein kinase mRNA M59287.1|HUMKINCDC 542 86 8E-144 
Homo sapiens CDC-like kinase 4, mRNA, complete cds BC136261.1 537 78 2E-61 
CDC-like kinase 1 EDL00074.1 507 100 1E-75 
      
Regulatory 
enzyme activity 
Putative protein kinase C regulatory protein S55223.1 435 82 3E-79 
Mus musculus tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide,mRNA BC049070.1 471 98 2E-154 
Homo sapiens mRNA similar to protein kinase, cAMP dependent regulatory seroserotype I beta BC002470.1 518 90 3E-163 
      
Transport 
Mus musculus ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA NM_007502.4 441 99 0 
Atp1b3 protein (ATPase, Na+/K+ transporting, beta 3 polypeptide) AAI14531.1 441 97 9E-39 
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Cytes pathway AF248636 Mus musculus lymphocyte antigen 108 isoform s mRNA, complete cds AF248636.1 544 100 1E-176 
Development 
Mus musculus histocompatibility 2, T region locus 23, mRNA, complete cds BC005648.1 319 99 2E-139 
myeloid nuclear differentiation antigen like D0QMC3.1 427 99 4E-85 
Mouse DNA sequence from clone RP23-353G2 on chromosome 2, complete sequence AL837506.3 421 91 1E-171 
Mnda protein (myeloid cell nuclear differentiation antigen) AAI45398.1 812 92 7E-76 
      
Others 
Mus musculus activated spleen cDNA, RIKEN full-length enriched library, clone: F830006H06 product: unclassifiable, full 
insert 
AK171721.1 369 94 2E-155 
mCG10725, isoform CRA_b EDL25591.1 485 100 4E-38 
mCG10725, isoform CRA_a EDL20953.1 485 97 9E-39 
mCG1027072 EDL10687.1 369 98 6E-35 
mCG1031612 EDK97144.1 298 83 2E-26 
mCG1029410 EDL13997.1 422 100 1E-81 




Table 3. List of identified genes from SSH-TB library. 
 
Classification Identified gene 
GenBank accession 





M. musculus DNA for desmin-binding fragment DesA7 AJ403263.1 409 96 3E-168 
M. musculus DNA for desmin-binding fragment DesA17 AJ403273.1 512 91 2E-145 
M. musculus DNA for desmin-binding fragment DesA25 AJ403281.1 392 94 2E-86 
M. musculus DNA for desmin-binding fragment DesB15 AJ403312.1 508 91 9E-134 
M. musculus DNA for desmin-binding fragment DesB16 AJ403313.1 569 90 3E-153 
M. musculus DNA for desmin-binding fragment DesB20 AJ403317.1 519 91 3E-143 
M. musculus DNA for desmin-binding fragment DesB29 AJ403326.1 545 93 4E-157 
M. musculus DNA for desmin-binding fragment DesB38 AJ403335.1 431 92 1E-157 
M. musculus DNA for desmin-binding fragment DesD19 AJ403398.1 445 93 1E-82 
M. musculus DNA for desmin-binding fragment DesD23 AJ403402.1 515 94 2E-134 
M. musculus DNA for desmin-binding fragment DesD25 AJ403404.1 477 91 3E-163 
M. musculus DNA for vimentin-binding fragment VimC2 AJ403137.1 293 94 7E-85 
M. musculus DNA for vimentin-binding fragment VimE5 AJ403237.1 627 89 5E-176 
M. musculus DNA for vimentin-binding fragment VimE9 AJ403241.1 455 97 3E-168 
M. musculus DNA for vimentin-binding fragment VimE22 AJ403254.1 488 93 3E-83 
M. musculus DNA for vimentin-binding fragment VimG17 AJ403224.1 384 94 8E-15 
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M. musculus DNA for GFAP-binding fragment GFAPE3 AJ403645.1 309 95 8E-164 
M. musculus DNA for GFAP-binding fragment GFAPE5 AJ403647.1 349 94 3E-168 
M. musculus DNA for GFAP-binding fragment GFAPE20 AJ403402.1 272 93 3E-83 
Mus musculus guanylate binding protein 4 (Gbp4), mRNA NM_008620.3 221 99 9E-109 
Mus musculus guanylate binding protein 6 (Gbp6), mRNA NM_194336.2 232 93 5E-91 
M. musculus mRNA for poly(A) binding protein X65553.1 347 100 3E-128 
Murine gene 37 for pot. membrane bound protein Y00629.1 307 96 7E-55 
poly(A) binding protein, cytoplasmic 1 (Pabpc1 protein) AAH04587.1 503 100 7E-16 
poly(A) binding protein, cytoplasmic 2 AAB70164.1 338 75 5E-08 
poly(A) binding protein, cytoplasmic 4 CAM46095.1 398 100 1E-11 
poly(A) binding protein, cytoplasmic 6 EDL02091.1 362 80 3E-10 
Rattus norvegicus RNA-binding region containing protein 2-like, mRNA NM_001177904.1 528 95 5E-146 
      
Physiology 
pathway 
Mus musculus tripartite motif-containing 25 (Trim25), mRNA NM_009546.2 372 98 8E-159 
Mus musculus lysozyme 2, mRNA (cDNA clone MGC:62600, IMAGE:6514977), complete cds    BC054463.1 218 100 2E-109 
Mus musculus lysozyme 1 (Lyz1), mRNA NM_013590.4 210 96 2E-95 
Mus musculus mRNA for mKIAA4245 protein AK220567.1 303 99 1E-111 
Mus musculus macrophage activation 2 like protein, mRNA , complete cds   BC007143.1 258 93 2E-95 
MUSEFP Mus musculus mRNA for estrogen responsive finger protein, complete cds    D63902.1 375 99 1E-142 
Mus musculus interferon-induced protein with Tetratricopeptide repeats 3, mRNA, complete cds BC003804.1 604 99 4E-137 
Mus musculus interferon activated gene 204 (Ifi204), mRNA NM_008329.2 530 98 0 
Mus musculus interferon activated gene 205 (Ifi205), mRNA NM_172648.3 510 93 0 
Mus musculus interferon activated gene 202B (Ifi202b), transcript variant 1, mRNA NM_008327.2 502 82 3E-78 
PREDICTED: Mus musculus interferon-activable protein 202-like, mRNA XM_001473873.2 502 82 2E-76 
Mus musculus glucocorticoid-attenuated response gene 49 (GARG-49/IRG2) mRNA, complete cds U43086.1|MMU43086 604 99 7E-135 
HUMRNPB1A Human hnRNP B1 protein mRNA M29064.1 465 99 0 
interferon-activatable protein AAA39313.1 658 95 1E-77 
Mus musculus strain NZB lupus susceptibility protein p202 (Ifi202a) mRNA    DQ222946.1 604 82 7E-75 
phosphatidylserine decarboxylase, isoform CRA-d(EC:4.1.1.65) EAW59990.1 188 79 1E-18 
phosphatidylserine decarboxylase, isoform CRA-b (EC:4.1.1.65) EAW59985.1 188 83 5E-18 
Mus musculus premature mRNA for mFLJ00102 protein AK220304.1 408 98 8E-174 
Homo sapiens mRNA for BM-010 variant protein AB209021.1 190 95 3E-79 
Samd9l protein (sterile alpha motif domain containing 9-like) AAH31151.2 781 100 4E-84 
Pb-fam-2 protein   XP_675977.1 407 77 E-133 
Mus musculus phosphatase and tensin homolog (Pten), mRNA (EC:3.1.3.36) NM_008960.2 262 99 3E-50 
Mus musculus phosphatidylserine decarboxylase (Pisd), mRNA (EC:4.1.1.65) NM_177298.3 721 96 5E-63 
      




Table 3 Contd 
 
Catalytic activity 
Rattus norvegicus NCK (choline kinase) associated protein 1 like (Nckap1l), mRNA NM_001108119.1 459 92 1E-151 
Cytochrome oxidase subunit 1 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide I) (Cytochrome c oxidase subunit I) homolog     AK136262.1 344 100 1E-157 
Mus musculus GTF2IRD1 (glucosyltransferase 1, insulin resistance diabetes1) and CYLN2 genes complete cds         AF289667.1|AF289667 568 94 9E-79 
cytochrome c oxidase subunit I BAA95618.1 344 87 2E-27 
cytochrome c oxidase subunit III ABK79255.1 438 90 1E-50 
Mus musculus GTPase, IMAP family member 6 (Gimap6), mRNA BC028779.1 408 98 2E-170 
PREDICTED: Mus musculus heterogeneous nuclear ribonucleoproteins A2/B1-like (LOC100045191)                              XM_001473825.2 470 100 4E-47 




Mus musculus lysozyme 2, mRNA (cDNA clone MGC:62600 IMAGE:6514977), complete cds BC094422.1 223 98 1E-107 
Mus musculus eukaryotic translation initiation factor 4A2 (Eif4a2), transcript variant 3, mRNA NM_001123038.1 199 100 9E-99 
Homo sapiens replication factor C (activator 1) 4 (37kD) (RFC4) gene, complete cds   AF538718.1 201 95 3E-79 
Mus musculus eukaryotic translation elongation factor 1 alpha 1, mRNA, complete cds   BC108391.1 308 100 2E-135 
MUSEFTU Mus musculus protein synthesis elongation factor Tu (eEF-Tu, eEf-1-alpha) mRNA, complete cds         M22432.1 302 98 5E-111 
MUSMHCQA1A Mus musculus MHC class I Qa-1a antigen mRNA, complete cds   L00606.1 319 99 4E-132 
Rattus norvegicus similar to chromosome 1 open reading frame 63, mRNA, complete cds   BC085888.1 359 87 2E-124 
MUSSATA Mouse satellite DNA M17407.1 389 94 1E-152 
Mus musculus PRP38 pre-mRNA processing factor 38 (yeast) domain containing B, mRNA    NM_025845.2 388 100 7E-80 
Human DNA sequence from clone RP11-449I17 on chromosome 10, A transcriptional regulator (yeast) (SIN3A) and a CpG 
island, complete sequence                              
AL161651.13 580 80 5E-116 
      
Signal 
transduction 
Mus musculus KH domain containing, RNA binding, signal transduction associated 1 (Khdrbs1), mRNA         NM_011317.3 433 99 2E-180 
Mus sp. JAK1 protein tyrosine kinase mRNA,complete cds S63728.1|S63728 284 99 2E-110 
Homo sapiens mRNA similar to protein kinase, cAMP dependent Regulatory seroserotype I beta   BC002470.1 518 90 3E-163 
CDC-like kinase 1   EDL00074.1 507 100 1E-75 
serine threonine tyrosine kinase AAA40151.1 589 99 1E-74 
Clk4 protein AAH02220.1 355 83 6E-62 
Homo sapiens cDNA FLJ56064 complete cds, highly similar to Dual specificity protein kinase CLK1 (EC 2.7.12.1)       AK294295.1 426 86 2E-145 
Homo sapiens mitogen-activated protein kinase kinase kinase 8 (MAP3K8), mRNA  NM_005204.2 563 80 5E-116 
Human protein kinase mRNA M59287.1|HUMKINCDC 542 86 8E-144 
Homo sapiens CDC-like kinase 4, mRNA (cDNA clone MGC:167871 IMAGE:9020248), complete cds BC136261.1 536 78 2E-61 
Homo sapiens mRNA for proto-oncogene protein, complete cds D14497.1|HUMPOPSTK 528 79 3E-108 
      
Regulatory 
enzyme activity 
AF081957 Synthetic construct aminoglycoside 3'-phosphotransferase,mutant (mNeo) gene, complete cds   AF081957.1 258 100 2E-11 
Mus musculus tyrosine 3-monooxygenase/tryptophan 5-monooxygenase, activation protein, beta polypeptide,mRNA BC049070.1 471 98 2E-154 
14-3-3 protein beta subseroserotype=putative protein kinase C, regulatory protein S55223.1 435 82 3E-79 
      








Mus musculus ribosomal protein S28, mRNA ,complete cds BC010987.1 340 98 1E-106 
Mus musculus ribosomal protein S28, mRNA ,complete cds BC090982.1 361 96 1E-96 
Mus musculus C57BL/6J ribosomal protein S28 mRNA, complete cds U11248.1|MMU11248 298 99 3E-94 
Rattus norvegicus ribosomal protein S15a, mRNA, complete cds BC058452.1 353 94 3E-163 
PREDICTED: Rattus norvegicus similar to 40S ribosomal protein, S28 (LOC689805), mRNA XM_002725838.1 210 92 5E-34 
ribosomal protein S25 P62852.1 366 100 4E-36 
Ly108 (SLAM family member 6) ACF05482.1 544 100 4E-07 
      
Transport 
Mus musculus ATPase, Na+/K+ transporting, beta 3,polypeptide (Atp1b3), mRNA NM_007502.4 441 99 0 
Atp1b3 protein (ATPase, Na+/K+ transporting, beta 3 polypeptide) AAI14531.1 441 97 9E-39 
      
Cytes pathway AF248636 Mus musculus lymphocyte antigen 108 isoforms mRNA, complete cds      AF248636.1 544 100 1E-176 
      
Development 
Mus musculus histocompatibility 2, T region locus 23, mRNA, complete cds BC005648.1 319 99 2E-139 
Mouse DNA sequence from clone RP23-353G2 on chromosome 2, complete sequence AL837506.3 421 91 1E-171 
myeloid nuclear differentiation antigen like D0QMC3.1 427 99 4E-85 
Mnda protein (myeloid cell nuclear differentiation antigen) AAI45398.1 812 92 7E-76 
      
Others 
Mus musculus activated spleen cDNA, RIKEN full-length enriched library, clone: F830006H06 product: unclassifiable, full 
insert 
AK171721.1 369 94 2E-155 
mCG10725, isoform CRA_b EDL25591.1 485 100 4E-38 
mCG21656, isoform CRA_a EDL20953.1 485 97 9E-39 
mCG1027072 EDL10687.1 369 98 6E-35 
mCG1031612 EDK97144.1 298 83 2E-26 
mCG1029410 EDL13997.1 422 100 1E-81 




China. SS2 is the prevalent S. suis serotype in 
Chinese diseased pigs, and although several 
proteins have been identified as candidate 
vaccines to control S. suis (Baums and Valentin-
Weigand, 2009; Feng et al., 2010), the 
mechanism of SS2 pathogenesis is still not well 
understood. Several pathogenic factors were 
successfully identified, and these have helped to 
improve our understanding of the virulence of this 
bacterium. As infectious disease results from 
interplay between the pathogen and the host 
defense mechanism, characterization of the host 
immune response is essential to a full 
understanding of the disease process (de Greeff 
et al., 2010). In the present study, the mortality 
rates for A/J and C57BL/6 mice infected by 
HA9801 were 68.75 and 25.0%, respectively. This 
infers that A/J mice are more susceptible to 
HA9801 infection than are C57BL/6 mice, which is 
consistent with the results of Domínguez-Punaro 
Mde et al. (2008). This latter group reported that 
A/J mice are more susceptible to S. suis infection 
than are C57BL/6 mice, especially during the 
acute septic phase of the infection, and that a 
balance between pro- and anti-inflammatory 
mediators is crucial for survival during the septic 
phase. 


































































Figure 4. Functional categories analysis of differentially expressed tags functional 





The suppression subtractive hybridization (SSH) 
technique  is  an  efficient  and  widely  used  PCR-based 
method that is used to isolate differentially expressed 
genes (Hayashi and Spencer., 2005; Tang et al., 2009). In




Table 4. List of possible differentially expression proteins in mouse spleen infected with S. suis serotype 2. 
 
Strain Putative differentially expressed protein 
A/J mouse strain 
desmin-binding fragment Des B4 
vimentin-binding fragment Vim (C35、C44) 
GFAP-binding fragment GFAPE11 
RNA binding motif protein 39 (Rbm39) 
  
C57BL/6 mouse strain 
desmin-binding fragment Des(B20、D19、D23、D25) 
vimentin-binding fragment Vim(C2、G17) 






macrophage activation 2 like protein 
protein synthesis elongation factor Tu (eEF-Tu, eEf-1-alpha) 
interferon-induced protein with Tetratricopeptide repeats 3 
interferon-activable protein 202-like 
NZB lupus susceptibility protein 
Cytochrome c oxidase subunit 1 
Cytochrome c oxidase subunit III 
Ly108 protein (SLAM family member 6) 
phosphatase  
Phosphatidylserine decarboxylase 
Phosphatidylserine decarboxylase -CRA-b 
Phosphatidylserine decarboxylase -CRA-d 






the current study, subtractive hybridization libraries were 
constructed by SSH, and differentially expressed genes 
(116 ESTs fragments from the SSH-TA library and 138 
ESTs fragments from the SSH-TB library) were found to 
be highly homologous (above 95%), with known 
sequences deposited in GenBank. Further analysis 
indicated that the ESTs from the SSH-TA and SSH-TB 
library genes are involved in numerous and diverse 
physiological functions. Li et al. (2010) studied the gene 
expression profiles from spleen tissue obtained from pigs 
that had suffered from highly pathogenic S. suis, and the 
results showed that the majority of down-regulated genes 
were involved in transcription, transport, energy 
metabolism and immune function (the majority of the up-
regulated genes). Interestingly, the regulatory signal 
transduction genes increased from 11% in the SSH-TA 
library to 12% in the SSH-TB library, and regulatory cell 
apoptosis genes appeared only in the SSH-TB library. 
The data indicate that C57BL/6 mice cells may be more 
susceptible to apoptosis following infection with the S. 
suis pathogen than are cells from A/J mice. Also, the 
results showed that some genes involved in immune 
function (lysozyme, interferon-actively protein, 
macrophage activation 2 like protein, complement 
component-3 and Ly108 protein), phospholipid 
metabolism (phosphatase), protein synthesis 
(transcription and elongation factors), signal transduction 
(CDC-like kinase 1, serine/threonine kinase, Clk4 protein) 
and ribosomal protein structure were selected from the 
spleen of C57BL/6 mice following HA9801 infection. 
Lysozyme is a well-known anti-microbial protein that 
has been detected in the body fluids and tissues from 
many bivalve mollusks, and it is believed to play a role in 
host defense and digestion (Allam et al., 2000; Cronin et 
al., 2001). Ordás et al. (2000) reported that lysozyme 
concentrations changed in clams (Tapes decussatus) 
infected by Perkinsus atlanticus, and Chu and La Peyre. 





 (Crassostrea virginica) infected by Perkinsus marinus. 
Results reported herein describe up-regulation of 
lysozyme gene expression in the spleen of C57BL/6 mice 
infected by HA9801, which suggests that lysozyme may 
protect the body against damage by exogenous 
pathogenic bacteria. 
Interferon is a broad-spectrum antiviral agent that does 
not directly inhibit or kill viruses. Instead, it induces anti-
viral protein synthesis following interaction with cell 
surface receptors, thereby inhibiting viral replication. Data 
presented here show that interferon-activated protein and 
interferon-induced protein genes are highly expressed in 
C57BL/6 mice infected with strain HA9801. Li et al. 
(2010) reported that interferon-induced transmembrane 
protein levels increased 2-fold in spleens three days 
subsequent to S. suis infection, while Wu et al. (2010) 
found that the level of interferon regulatory factor 11 was 
elevated in zebrafish infected with SS2 strain HA9801. 
Interferon-activated protein is a cytokine that is produced 
by mononuclear cells and lymphocytes. It enhances the 
vitality of natural killer cells, macrophages and T 
lymphocytes, and it is involved in immunoregulation 
(Demmers et al., 2001). Given these results, we 
hypothesize that interferon protein gene expression in 
C57BL/6 mice infected with strain HA9801 is up-
regulated to improve exogenous pathogen resistance by 
enhancing natural killer cell, macrophage and T 
lymphocyte vitality. 
Macrophage activation 2 like protein is initiated by 
lymphokines, and it can alter the morphology and 
functional activity of macrophages. Stimulated 
macrophages can produce interleukin (IL)-1β, tumour 
necrosis factor (TNF), IL-18 and antiviral interferon (IFN) 
(Pirhonen et al., 1999). In A/J mice, increased IL-12 
expression may have been associated with the induction 
of high levels of IFN-γ, a cytokine known for its potent 
ability to activate macrophages and enhance TNF-γ 
synthesis, thereby exacerbating mortality (Heinzel et al., 
1994). In this study, macrophage activation 2 like protein 
was highly expressed in HA9801 infected C57BL/6 mice. 
This is consistent with the work of Wu et al. (2010), who 
reported elevated levels of macrophage stimulating 1 in 
zebrafish infected with SS2 strain HA9801. Human and 
murine monocytes/macrophages recognize whole S. suis 
or its purified cell wall components primarily through a 
toll-like receptor 2 (TLR2)- dependent pathway (Graveline 
et al., 2007). Monocyte-derived macrophages also 
demonstrate a capacity to kill S. suis in the absence or 
presence of specific antibodies, depending on the 
bacterial strain they are exposed to (Andresen and 
Tegtmwier., 2001). High levels of cytokines and 
chemokines could be released by macrophages (Segura 
et al., 1999) and monocytes (Segura et al., 2002) by S. 
suis   stimulation,  and  these  could  be  important  in the  
initiation and development of inflammation and meningitis 
(Domínguez-Punaro et al., 2007). This suggests that 
macrophage   activation   is   sequelae  to  and  a  cellular  




source of anti-inflammatory cytokines in the spleen of 
mice following strain HA9801 infection. 
The complement system is an important part of the 
immune system and induction of those genes associated 
with complement activation and other immune system 
components represents an essential step in the 
organism’s overall defense against pathogen invasion. 
KEGG pathway analysis revealed that genes involved in 
complement and coagulation cascades were up-
regulated in zebrafish following S. suis infection (Wu et 
al., 2010), and Chabot-Roy et al. (2006) demonstrated 
the importance of complement and specific antibodies in 
the bactericidal activity of leukocytes against S. suis. In 
this study, the complement component 3 (C3) gene was 
induced in C57BL/6 mice after infection with strain 
HA9801. Complement activation leads to cleavage of C3, 
and the resultant products initiate a cascade of events, 
producing several physiologically active molecules 
(Walport et al., 2001). C3 and its products migrate to sites 
of infection where they may activate pro-inflammatory 
cells. These cells secrete inflammatory mediators and 
cytokines, which assist in the overall immune response to 
the S. suis infected in C57BL/6 mice. Additional study of 
C3 and the pathogenesis of SS2 strain HA9801 infections 
in C56BL/6 mice will further clarify this relationship. 
Ly108 is a member of the mouse CD family of cell 
surface proteins (Peck and Ruley., 2000). These proteins 
contain similar immunoglobulin domains, which activate 
natural killer (NK) cells and lymphocytes. Through the 
combined effects of homologous Src-2 protein domains, 
phosphatase SH2 domains and tyrosine phosphorylation, 
these proteins resist the invasion of foreign bacteria 
(Gray et al., 2000; Bottino et al., 2001; Valdez et al., 
2004). Our results show that Ly108 protein gene 
expression was enriched in C57BL/6 mice after strain 
HA9801 infection. Although the exact mechanisms 
underlying the inflammatory response induced by S. suis 
is unknown, in vitro experiments have shown that 
cytokine and chemokine production by S. suis-activated 
phagocytes is mediated through CD14-dependent and 
independent pathways (Segura et al., 2002). Segura et 
al. (2002) also demonstrated that S. suis is recognized 
primarily by TLR2, which is associated with CD14, 
leading to the release of pro-inflammatory mediators 
(Graveline et al., 2007). Activation of TLR2 and CD14 
was also observed in murine brain parenchyma after 
exposure to S. suis (Domínguez-Punaro et al., 2007). Li 
et al. (2010) found that TLR2 and CD14 were elevated 2-
fold and 3.4-fold, respectively, at the transcript level in 
spleen tissue following infection with highly pathogenic S. 
suis. Thus, Ly108 protein could play an important role in 
the host response to infection by S. suis in C57BL/6 
mice. 
Genes  involved  in  phospholipid  metabolism were up- 
regulated in splenic tissue obtained from C57BL/6 mice 
infected with strain HA9801. Phospholipids are the main 
constituents   of   biological  membranes,  and  they  have 




important regulatory as well as structural functions in 
membranes. Phosphatase gene expression was up-
regulated in C57BL/6 mouse spleen after strain HA9801 
infection. Phosphatase activity may generate 
phosphatidylinositols (PIs) which have been found to play 
an important role in cellular signaling and intracellular 
trafficking (Krauss and Haucke.,2007). 
Phosphotidylinositols can be phosphorylated by 
phosphatidylinositol kinase, producing a variety of second 
messengers, such as inositol-1,4,5-triphosphate (IP3) 
and diglyceride (DG) (Manning and Cantley, 2007). 
Those second messengers can activate protein kinase 
thus activating many downstream signaling proteins that 
regulate cell survival and cell cycle progress. Consistent 
with this result, serine/threonine kinase and CDC-like 
kinase-1 gene expression were also elevated in the 
spleen of C57BL/6 mice after strain HA9801 infection. 
Protein kinase activates MAP-kinases and the NF-κB sig-
naling pathway, which are closely related to tumor cell 
apoptosis, regulation and development (Liu and 
Xia.,2006). de Greeff et al. (2010) reported that NF-kB 
and MAP-kinase signaling pathways were induced upon 
interaction with SS2. In a study by Domínguez-Punaro et 
al. (2007), robust and rapid expression of TLR2, IkBa and 
CCL2 (MCP-1) was evident in the choroid plexus of mice 
soon after they were infected with S. suis. Recent work 
by Wichgers Schreur et al. (2010) revealed that compo-
nents released during S. suis infection, as well as in 
penicillin-treated whole bacteria, could induce NF-kB 
activation through TLR2/6. Thus, we speculate that sig-
naling pathways associated with phospholipid metabolism 
could play an important role in defending against S. suis 
infection in C57BL/6 mice. It was also observed that the 
phosphatidylserine decarboxylase gene was highly 
expressed in the spleen of C57BL/6 mice following strain 
HA9801 infection. Phos-phatidylserine decarboxylase 
catalyzes phos-phatidylserine decarboxylation, gene-
rating phos-phatidylethanolamine in prokaryotes (Kanfer 
and Kennedy, 1964). So, the precise mechanism by 
which the phosphatidylserine decarboxylase gene was 
induced in the spleen of C57BL/6 HA9801 infected mice 
is open to further investigation. 
The data indicate that genes involved in the immune 
response and in phospholipid metabolism are up-
regulated to a greater extent in C57BL/6 mice splenic 
tissue than are similar genes in A/J mice splenic tissue 
following infection with S. suis strain HA9801. Although 
further investigation of the role that phospholipid me-
tabolism signaling pathways play in protecting against S. 
suis infection may be needed, this study provides 
evidence that, besides the host immune response, 
phospholipid metabolism represents another important 
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S. suis, Streptococcus suis; SS2, Streptococcus suis serotype 
2; SSH, suppression subtractive hybridization; THB, Todd-
Hewitt broth; PBS, phosphate-buffered saline; i.p., 
intraperitoneal; TNF, tumor necrosis factor; IFN, interferon; TLR, 
Toll-like receptor; C3, complement component 3; SH2, Src 
homology 2; cDNA, complementary deoxyribonucleic acid; 
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